|
2025 Journal Article Emerging antimicrobial therapies for Gram-negative infections in human clinical useHickson, Sarah M., Ledger, Emma L. and Wells, Timothy J. (2025). Emerging antimicrobial therapies for Gram-negative infections in human clinical use. npj Antimicrobials and Resistance, 3 (1) 16. doi: 10.1038/s44259-025-00087-2 |
|
2024 Journal Article Cloaking antibodies are prevalent in Burkholderia cepacia complex infection and their removal restores serum killingPham, Amy, Tan, Kellynn K. Y., Ledger, Emma L., Smith, Daniel J., Reid, David W., Burr, Lucy, Chambers, Daniel C. and Wells, Timothy J. (2024). Cloaking antibodies are prevalent in Burkholderia cepacia complex infection and their removal restores serum killing. Frontiers in Cellular and Infection Microbiology, 14 1426773. doi: 10.3389/fcimb.2024.1426773 |
|
2024 Conference Publication Does a leopard change its spots? Pseudomonas aeruginosa in cystic fibrosis after CFTR modulationLedger, Emma, Smith, Daniel, Teh, Jing Jie, Wood, Michelle, Whibley, Page, Morrison, Mark, Goldberg, Joanna, Reid, David and Wells, Timothy (2024). Does a leopard change its spots? Pseudomonas aeruginosa in cystic fibrosis after CFTR modulation. Abstracts of the 15th Australasian Cystic Fibrosis Conference, Brisbane, QLD, Australia, 2–4 August 2024. Richmond, VIC, Australia: John Wiley & Sons. |
|
2024 Journal Article Impact of CFTR modulation on Pseudomonas aeruginosa infection in people with cystic fibrosisLedger, Emma L., Smith, Daniel J., Teh, Jing Jie, Wood, Michelle E., Whibley, Page E., Morrison, Mark, Goldberg, Joanna B., Reid, David W. and Wells, Timothy J. (2024). Impact of CFTR modulation on Pseudomonas aeruginosa infection in people with cystic fibrosis. The Journal of Infectious Diseases, 230 (3), e536-e547. doi: 10.1093/infdis/jiae051 |
|
2021 Journal Article Inferior outcomes in lung transplant recipients with serum Pseudomonas aeruginosa specific cloaking antibodiesDivithotawela, Chandima, Pham, Amy, Bell, Peter T., Ledger, Emma L., Tan, Maxine, Yerkovich, Stephanie, Grant, Michelle, Hopkins, Peter M., Wells, Timothy J. and Chambers, Daniel C. (2021). Inferior outcomes in lung transplant recipients with serum Pseudomonas aeruginosa specific cloaking antibodies. The Journal of Heart and Lung Transplantation, 40 (9), 951-959. doi: 10.1016/j.healun.2021.05.016 |
|
2021 Journal Article Anti-LPS IgA and IgG can inhibit serum killing of Pseudomonas aeruginosa in patients with cystic fibrosisPham, Amy, Ledger, Emma L., Coggon, Carrie F., Henderson, Ian R., Reid, David W., Bell, Scott C., Smith, Daniel J. and Wells, Timothy J. (2021). Anti-LPS IgA and IgG can inhibit serum killing of Pseudomonas aeruginosa in patients with cystic fibrosis. Infection and Immunity, 89 (12) e00412-21, e0041221. doi: 10.1128/iai.00412-21 |
|
2020 Journal Article Genetic, morphological and antigenic relationships between mesonivirus isolates from Australian mosquitoes and evidence for their horizontal transmissionNewton, Natalee D., Colmant, Agathe M. G., O’Brien, Caitlin A., Ledger, Emma, Paramitha, Devina, Bielefeldt-Ohmann, Helle, Watterson, Daniel, McLean, Breeanna J., Hall-Mendelin, Sonja, Warrilow, David, van den Hurk, Andrew F., Liu, Wenjun, Hoare, Christina, Kizu, Joanne R., Gauci, Penelope J., Haniotis, John, Doggett, Stephen L., Shaban, Babak, Johansen, Cheryl A., Hall, Roy A. and Hobson-Peters, Jody (2020). Genetic, morphological and antigenic relationships between mesonivirus isolates from Australian mosquitoes and evidence for their horizontal transmission. Viruses, 12 (10) 1159, 1159. doi: 10.3390/v12101159 |
|
2020 Conference Publication A Novel Pseudomonas aeruginosa Virulence Factor Predicts CLAD and Death after Lung TransplantationDivithotawela, C., Pham, A., Ledger, E. L., Hopkins, P., Tan, M., Yerkovich, S., Wells, T. J. and Chambers, D. C. (2020). A Novel Pseudomonas aeruginosa Virulence Factor Predicts CLAD and Death after Lung Transplantation. 40th Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation (ISHLT), Montreal, Canada, 22-25 April 2020. New York, NY United States: Elsevier. |
|
2020 Journal Article Treatment of life-threatening Pseudomonas aeruginosa infection by pheresis of inhibitory antibodiesDivithotawela, Chandima, Pham, Amy, Ledger, Emma L., Hopkins, Peter, Wells, Timothy J. and Chambers, Daniel (2020). Treatment of life-threatening Pseudomonas aeruginosa infection by pheresis of inhibitory antibodies. Journal of Heart and Lung Transplantation, 39 (1), 87-89. doi: 10.1016/j.healun.2019.10.001 |
